CN104356075B - Refining method for increasing bulk density and fluidity of sulfadiazine - Google Patents

Refining method for increasing bulk density and fluidity of sulfadiazine Download PDF

Info

Publication number
CN104356075B
CN104356075B CN201410629018.8A CN201410629018A CN104356075B CN 104356075 B CN104356075 B CN 104356075B CN 201410629018 A CN201410629018 A CN 201410629018A CN 104356075 B CN104356075 B CN 104356075B
Authority
CN
China
Prior art keywords
sulfadiazine
refining method
product
fluidity
bulk density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410629018.8A
Other languages
Chinese (zh)
Other versions
CN104356075A (en
Inventor
尹秋响
李康丽
吴送姑
孙佳
龚俊波
侯宝红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201410629018.8A priority Critical patent/CN104356075B/en
Publication of CN104356075A publication Critical patent/CN104356075A/en
Application granted granted Critical
Publication of CN104356075B publication Critical patent/CN104356075B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Abstract

The invention relates to a refining method for increasing the bulk density and the fluidity of sulfadiazine. The refining method comprises the following steps: adding rough sulfadiazine and organic solvents into a reaction kettle, wherein the organic solvents include N-methylpyrrolidone NMP, dimethylformamide DMF and dimethyl sulfoxide DMSO; stirring at a constant temperature, and adding activated carbon to carry out decoloration; after filtering, adding water into filtrate, cooling, filtering, and drying so as to obtain sulfadiazine crystals. According to the refining method, a high-temperature reaction cooling crystallization manner in a conventional process is replaced by a dilution crystallization manner by virtue of the organic solvents and water, so that the consumption of the solvents is greatly reduced, the whole technical process is simplified, the consumption and the loss of a great deal of energy caused by the high temperature are avoided, and an obtained sulfadiazine product is large in granularity and relatively good in bulk density and fluidity.

Description

A kind of process for purification for improving sulfadiazine heap density and mobility
Technical field
The invention belongs to Chemical Engineering pharmaceutical technology field, and in particular to a kind of to improve sulfadiazine heap density and mobility Process for purification
Background technology
Sulfadiazine (SD) belongs to median acting sulfonamide class medicine.Molecular formula C10H10N4O2S, molecular weight 250.28, its chemical name Referred to as:Sulfadiazine.Chemical structural formula is:
Sulfadiazine is one of larger product of yield in sulfa drugss, domestic to adopt propilolic alcohol method or vinyl second Ether method synthesizes.The process for purification of sulfadiazine crude product is that sulfadiazine is prepared into calcium salt first by reactive crystallization, adds activity Charcoal adsorption-edulcoration, is precipitated with acetic acid after filtration and obtains finished product.Obtained product quality is light in this way, and heap density exists 0.34g/mL~0.45g/mL, granularity are little, and main granularity is generally less than 100 μm, characterize generally higher than 43 ° of the angle of repose of mobility, Dust from flying in production process, wastes larger.Foreign countries are that sulfadiazine crude product and ammonium hydroxide are made ammonium salt, through decolourizing Afterwards, carbon dioxide precipitates are passed through or sulfadiazine fine work is prepared using decompression ammonia excretion method.But sulfadiazine ammonium salt leads to Enter carbon dioxide precipitates not exclusively, yield is low, and using decompression ammonia excretion method as the ammonia excretion time is long, often product color be rubescent, Affect quality.Reagent dosage for occurring in sulfadiazine subtractive process is more, power consumption, the problems such as product quality is bad, this Bright to be intended to propose a kind of new process for purification, improve product quality makes whole technological process simple.
The content of the invention
It is an object of the invention to provide a kind of reducing energy consumption, reduces solvent load, sulfadiazine heap density and grain are improved The process for purification of degree.
The technical solution adopted for the present invention to solve the technical problems is:It is a kind of to improve sulfadiazine heap density and mobility Process for purification, processing step is:Add in the reactor sulfadiazine crude product and the organic solvent, organic solvent can be:N- Methyl pyrrolidone NMP, dimethylformamide DMF, dimethyl sulfoxide DMSO;Sulfadiazine with the mass ratio of organic solvent is: 1:2~7, at 40 DEG C~70 DEG C, optimum is stirred at 50 DEG C~60 DEG C steady temperature, adds sulfadiazine mass fraction 1% Activated carbon decolorizing, after filtration, adds water toward filtrate, water and Zhi Liang Bi≤1 of organic solvent, after adding water, drops whole system Temperature is cooled to final temperature for 0~30 DEG C, filters, be drying to obtain sulfadiazine crystal after stablizing.
Author Ding Xue by force document heavy sulfadiazine development it is medium mention, the refined sulfanilamide of reaction-crystallization method is phonetic Pyridine, the solvent load of needs are 25~35 times of crude product quality, and system needs to be warmed up to more than 80 DEG C and could react complete, in order to Reducing energy consumption, reduces solvent, and reactive crystallization is changed into dilution crystallization by the present invention, it is to avoid high temperature, substantially reduce the number solvent load. Sulfadiazine with the mass ratio of N-Methyl pyrrolidone is:1:2~7, the ratio of water and N-Methyl pyrrolidone is more than or equal to 1: 1。
The invention has the beneficial effects as follows:Replace conventional process high temperature reactive crystallization with dissolved crystallisation by cooling, not only make institute Obtain crystal heap density and granularity is greatly increased, and reduce energy consumption, reduce solvent load, technological operation letter It is single, it is easy to control.In drug manufacture, the heap density of particle, particle size, mobility have to the post processing processing characteristics of medicine Very big impact.The increase of heap density, mobility improve storage, the transport for being conducive to product;Be also beneficial to active constituents of medicine with it is auxiliary The mixing of material, also helps the subsequent processes such as tabletting or pelletize, so it is critically important one of subtractive process to improve particle propertiess Item index.By the process for refining in the present invention, the heap density of sulfadiazine can bring up to more than 0.6g/mL, and main granularity can To reach 200 microns, and there is good mobility, 35 ° can be reached angle of repose.
Description of the drawings
Process for refining schematic flow sheet of the accompanying drawing 1 for the present invention;
Microphotograph of the accompanying drawing 2 for 1 products obtained therefrom of embodiment;
XRD powder diagram of the accompanying drawing 3 for 1 products obtained therefrom of embodiment;
Particle size distribution figure of the accompanying drawing 4 for 1 products obtained therefrom of embodiment.
Specific embodiment
Below by by the specific embodiment of embodiment form, the above of the present invention is made further specifically It is bright.But this scope for being interpreted as above-mentioned theme of the invention should not be only limitted to following examples.It is all above-mentioned interior based on the present invention Hold realized technology and belong to the scope of the present invention.
Embodiment 1
By the 24gN- methyl pyrrolidones of 6g sulfadiazines dissolving crude product to 50 DEG C;Sulfadiazine quality is added after dissolving 1% activated carbon, decolourizes 30 minutes;Filter;By filtrate constant temperature after 60 DEG C, add water in filtrate dissolved, with constant in 2 hours Speed adds 24g deionized waters, separates out crystal;After dripping water, system is cooled to into 30 DEG C through 1h, constant temperature 20 minutes;Cross Filter, washing, is drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 36 ° according to GB11986-89 methods describeds, the heap density of product is 0.62g/mL, main 207.9 μm of granularity.The microphotograph of product, XRD spectrum and particle size distribution figure are as shown in accompanying drawing 2, accompanying drawing 3 and accompanying drawing 4.
Embodiment 2
By the 15gN- methyl pyrrolidones of 5g sulfadiazines dissolving crude product to 70 DEG C;Add the work of sulfadiazine quality 1% Property charcoal, decolourize 20 minutes;Filter;By filtrate constant temperature after 70 DEG C, add water in filtrate dissolved, is added with constant speed in 3 hours Enter 30g deionized waters, separate out crystal;After dripping water, system is cooled to into 20 DEG C through 1h, constant temperature 20 minutes;Filter, wash Wash, be drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 35.2 ° according to GB11986-89 methods describeds, the heap density of product is 0.64g/mL, 235.5 μm of main granularity.
Embodiment 3
By the 28gN- methyl pyrrolidones of 4g sulfadiazines dissolving crude product to 40 DEG C;Add the work of sulfadiazine quality 1% Property charcoal, decolourize 40 minutes;Filter;By filtrate constant temperature after 40 DEG C, add water in filtrate dissolved, is added with constant speed in 4 hours Enter 42g deionized waters, separate out crystal;After dripping water, system is cooled to into 0 DEG C through 1h, constant temperature 20 minutes;Filter, washing, It is drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 38.4 ° according to GB11986-89 methods describeds, the heap density of product is 0.57g/mL, 193.5 μm of main granularity.
Embodiment 4
By the 40gN- methyl pyrrolidones of 10g sulfadiazines dissolving crude product to 60 DEG C;Add sulfadiazine quality 1% Activated carbon, decolourizes 30 minutes;Filter;By filtrate constant temperature after 60 DEG C, add water in filtrate dissolved, with constant speed in 5 hours 80g deionized waters are added, crystal is separated out;After dripping water, system is cooled to into 20 DEG C through 1h, constant temperature 30 minutes;Filter, wash Wash, be drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 34.6 ° according to GB11986-89 methods describeds, the heap density of product is 0.67g/mL, 246.7 μm of main granularity.
Embodiment 5
By the 25g dimethylformamide DMF of 7g sulfadiazines dissolving crude product to 40 DEG C;Add sulfadiazine quality 1% Activated carbon, decolourizes 30 minutes;Filter;By filtrate constant temperature after 40 DEG C, add water in filtrate dissolved, with constant speed in 2.5 hours Degree adds 50g deionized waters, separates out crystal;After dripping water, system is cooled to into 20 DEG C through 0.5h, constant temperature 30 minutes;Cross Filter, washing, is drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 36.3 ° according to GB11986-89 methods describeds, the heap density of product is 0.61g/mL, 189.6 μm of main granularity.
Embodiment 6
By the 33g dimethyl sulfoxide DMSO of 11g sulfadiazines dissolving crude product to 55 DEG C;Add sulfadiazine quality 1% Activated carbon, decolourizes 20 minutes;Filter;By filtrate constant temperature after 55 DEG C, add water in filtrate dissolved, with constant speed in 4 hours 100g deionized waters are added, crystal is separated out;After dripping water, system is cooled to into 10 DEG C through 0.5h, constant temperature 30 minutes;Cross Filter, washing, is drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 35.5 ° according to GB11986-89 methods describeds, the heap density of product is 0.63g/mL, 204.5 μm of main granularity.
Embodiment 7
By the 30g dimethyl sulfoxide DMSO of 15g sulfadiazines dissolving crude product to 65 DEG C;Add sulfadiazine quality 1% Activated carbon, decolourizes 10 minutes;Filter;By filtrate constant temperature after 65 DEG C, add water in filtrate dissolved, with constant speed in 2 hours 50g deionized waters are added, crystal is separated out;After dripping water, system is cooled to into 10 DEG C through 1h, constant temperature 30 minutes;Filter, wash Wash, be drying to obtain sulfadiazine crystal.
Detect that the angle of repose of product is 35.5 ° according to GB11986-89 methods describeds, the heap density of product is 0.63g/mL, 204.5 μm of main granularity.

Claims (3)

1. a kind of method of the refined sulfadiazine for improving sulfadiazine heap density and mobility, is characterized in that adding in reactor Enter sulfadiazine crude product and organic solvent, stirring and dissolving under steady temperature, solution temperature are 40 DEG C~70 DEG C, add activated carbon to take off Color, after filtration, adds water toward filtrate, filters, be drying to obtain sulfadiazine crystal after being cooled to 0~30 DEG C;Wherein organic solvent It is N-Methyl pyrrolidone or dimethylformamide or dimethyl sulfoxide;Sulfadiazine crude product is 1 with the mass ratio of organic solvent: 2~7;Mass ratio≤1 of N-Methyl pyrrolidone or dimethylformamide or dimethyl sulfoxide and water.
2. a kind of as claimed in claim 1 method of the refined sulfadiazine for improving sulfadiazine heap density and mobility, which is special It is 50 DEG C~60 DEG C to levy the solution temperature described in being.
3. a kind of as claimed in claim 1 method of the refined sulfadiazine for improving sulfadiazine heap density and mobility, which is special The cooling final temperature described in being is levied at 15 DEG C~25 DEG C.
CN201410629018.8A 2014-11-10 2014-11-10 Refining method for increasing bulk density and fluidity of sulfadiazine Active CN104356075B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410629018.8A CN104356075B (en) 2014-11-10 2014-11-10 Refining method for increasing bulk density and fluidity of sulfadiazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410629018.8A CN104356075B (en) 2014-11-10 2014-11-10 Refining method for increasing bulk density and fluidity of sulfadiazine

Publications (2)

Publication Number Publication Date
CN104356075A CN104356075A (en) 2015-02-18
CN104356075B true CN104356075B (en) 2017-04-12

Family

ID=52523412

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410629018.8A Active CN104356075B (en) 2014-11-10 2014-11-10 Refining method for increasing bulk density and fluidity of sulfadiazine

Country Status (1)

Country Link
CN (1) CN104356075B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113831322A (en) * 2021-10-27 2021-12-24 安徽华星化工有限公司 Refining method of high-purity rimsulfuron

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484791A (en) * 1944-08-24 1949-10-11 American Cyanamid Co Purification of nu-substituted sulfanilamides
CN102603655A (en) * 2012-03-01 2012-07-25 上海化工研究院 Synthetic method of deuterium-marked sulfanilamide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484791A (en) * 1944-08-24 1949-10-11 American Cyanamid Co Purification of nu-substituted sulfanilamides
CN102603655A (en) * 2012-03-01 2012-07-25 上海化工研究院 Synthetic method of deuterium-marked sulfanilamide

Also Published As

Publication number Publication date
CN104356075A (en) 2015-02-18

Similar Documents

Publication Publication Date Title
CN105648022B (en) A kind of technique that liquid 6-APA leads directly to Amoxicillin
CN102850411B (en) Preparation method of D-glucosamine sulfate potassium chloride salt
CN101570543B (en) Preparation method of mezlocillin sodium solvent crystal
CN104555959A (en) Method for preparing lithium hexafluorophosphate quickly
CN101748515B (en) Method for recovering ionic liquid
CN103275150B (en) A kind of refining and preparation method of erythromycin thiocyanate
CN103204823A (en) Method for purifying 1, 2-benzisothiazole-3-ketone
CN104356075B (en) Refining method for increasing bulk density and fluidity of sulfadiazine
CN106810442B (en) A kind of production method of high-quality adipic acid
CN113185485B (en) Semi-synthesis method of dihydroquercetin
CN103896930A (en) Method for preparing pharmaceutical crystal form of Canagliflozin hemihydrates
CN102344426A (en) Method for extracting and purifying lovastatin
CN103265444A (en) Crystallization method of 5-aminolevulinic acid phosphate
CN102126756B (en) Method for producing industrial grade ammonium paramolybdate
WO2023051728A1 (en) Method for recovering lithium from lithium-containing solution
CN102382072A (en) Method for refining D-cycloserine
CN106883227B (en) The method for preparing ergometrine by ergot fermentation waste
CN105061327B (en) A kind of synthetic method of sulfamethoxyplridazine
CN101284775B (en) Process for reclaiming 2-keto-L-gulonate by salting out method
CN102731340A (en) Preparation method of demethyl aureomycin hydrochloride
CN109052458B (en) Preparation process for preparing nanoscale tetrabasic lead sulfate crystal seeds by using waste lead storage batteries
CN111454255B (en) Preparation method of small-particle-size azilsartan
CN103910685A (en) Method used for purifying sulfadimoxine
CN103694280A (en) Method for extracting glucosamine hydrochloride from glucosamine hydrochloride-containing mother liquor
CN106749216A (en) A kind of process for purification of crystal formation A Azilsartans

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: 300350 District, Jinnan District, Tianjin Haihe Education Park, 135 beautiful road, Beiyang campus of Tianjin University

Patentee after: Tianjin University

Address before: 300072 Tianjin City, Nankai District Wei Jin Road No. 92, Tianjin University

Patentee before: Tianjin University

CP02 Change in the address of a patent holder